Device / Technology News

RSS

Genentech to pay Seattle Genetics $9.5M for renewing licenses under existing ADC collaboration agreement

Seattle Genetics, Inc. today announced that Genentech, Inc., a wholly owned member of the Roche Group, will pay $9.5 million to renew exclusive licenses to specific targets and extend the research term under the parties' existing antibody-drug conjugate (ADC) collaboration agreement. Under the terms of the agreement, Genentech has rights to use Seattle Genetics' ADC technology with antibodies against targets selected by Genentech.

20 Apr 2010

Total Pricing Systems of Moncton introduces PPS Assist!

Total Pricing Systems of Moncton, a leading communication services supplier to the pharmaceutical and medical device industry since 1991, has introduced Canada's first industry communication delivery and management approach that will significantly reduce the industries' ecological footprint while also donating money to health charities.

20 Apr 2010

MDx to better health care, cut costs and make personalized medicine a worldwide reality

The rapidly growing field of molecular diagnostics is addressing critical unmet needs in healthcare by enabling early disease detection and better disease segmentation, and by predicting relapse and response to therapy, according to a global industry review released today by Scientia Advisors.

20 Apr 2010

Investment report on Sequenom from MicroStockProfit.com

MicroStockProfit.com announces an investment report featuring Sequenom Inc. The report includes financial, comparative and investment analysis, and industry information you need to know to make an educated investment decision.

20 Apr 2010

Medical device industry leaders to meet with lawmakers, government officials at MDMA annual meeting

As the U.S. Food and Drug Administration is reviewing pivotal regulatory procedures for one of America's fastest growing sectors, industry leaders will gather to meet with lawmakers and government officials at the 16th Annual Meeting of the Medical Device Manufacturers Association on May 24-26, 2010 at the Park Hyatt in Washington, DC.

20 Apr 2010

AngioDynamics commences treatment in NanoKnife IRE System pilot study for HCC

AngioDynamics today announced the first patient treatment and growing enrollment in a pilot study of the use of the Company's NanoKnife® Irreversible Electroporation (IRE) System in the treatment of early stage hepatocellular carcinoma (HCC), or primary liver cancer. This clinical trial is being conducted under the supervision of Professor Jordi Bruix of the Barcelona Clinic Liver Cancer Group of the University of Barcelona and Professor Riccardo Lencioni of the University of Pisa School of Medicine.

20 Apr 2010

STERIS reaches agreement with FDA over liquid chemical sterilization system consent decree

STERIS Corporation today announced it has reached an agreement with the U.S. Food and Drug Administration (FDA) on the terms of a consent decree regarding its SYSTEM 1® liquid chemical sterilization system. Included in the agreement is a Transition Plan with a Rebate Program for current SYSTEM 1 Customers in the U.S. The consent decree is subject to approval by the U.S. District Court for the Northern District of Ohio.

20 Apr 2010

ATS Medical announces first ATS 3f Aortic Bioprosthesis commercial implant in China

ATS Medical, Inc., manufacturer and marketer of state-of-the-art cardiac surgery products and services today announced the first commercial implant of the ATS 3f® Aortic Bioprosthesis was recently completed by Liu Zhi Gang, MD at Fu Wai Hospital in Beijing, China. Fu Wai Hospital is the largest cardiac surgery center in Asia and a full line of ATS products are utilized by their surgeons. ATS received permission from the Chinese State Food and Drug Administration (SFDA) to market the ATS 3f Aortic Bioprosthesis in March.

20 Apr 2010

Optimal IMX implements MobileMD's HIE technologies and services

Optimal IMX continued to build on its industry leading radiology services business by selecting and implementing MobileMD's Health Information Exchange (HIE) technologies and services. Optimal uses MobileMD's turnkey technology and services to establish HIT connectivity and interoperability with their client facilities and physician community.

20 Apr 2010

NextBio announces new Sequence-Centric module for mining high throughput array and sequencing data

NextBio today announced the latest evolution of its innovative life science research platform, adding new capabilities for the integration and mining of high-throughput array and next-generation sequencing data. The new NextBio Sequence-Centric module enables researchers to effectively explore and utilize massive amounts of public and internally generated sequencing data, while allowing organizations to create corporate-wide genomic data platforms to serve the needs of their global research teams.

20 Apr 2010

Calmare pain therapy medical device reviewed at CTT's annual meeting of shareholders

Competitive Technologies, Inc. held its annual meeting of shareholders today at the Hilton Stamford Hotel and Executive Meeting Center in Stamford, Conn. John B. Nano, CTT's Chairman, President and CEO reviewed the company's performance and highlighted the exciting progress on its sales and distribution plan for its Calmare pain therapy medical device, and other selected technologies.

20 Apr 2010

Wellstar International to install TMI Imaging system in Torrance, California

Wellstar International Inc. has announced they will be installing a system in Torrance, California.

20 Apr 2010

Pre-clinical study results of BiTE antibody technology presented at AACR 2010

Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that results from studies highlighting pre-clinical advances with its proprietary BiTE antibody technology were presented at the American Association for Cancer Research Annual Meeting in Washington, DC.

20 Apr 2010

Gamma-prime fibrinogen test can help better predict people at risk for heart attack

A simple blood test can identify people who are at risk for a heart attack, including thousands who don't have high cholesterol, according to researchers at Oregon Health & Science University.

20 Apr 2010

EHSI incorporates outpatient treatment options into MedAnywhere HHC Module

Emerging Healthcare Solutions, Inc. revealed today that they are working to incorporate outpatient treatment options into the new MedAnywhere medical iPhone app and that the first module to be added to development will be for cost saving Hemochromatosis management.

20 Apr 2010

Magnetically guided nanoparticles for delivering DNA, cells and drugs

Scientists and engineers have used uniform magnetic fields to drive iron-bearing nanoparticles to metal stents in injured blood vessels, where the particles deliver a drug payload that successfully prevents blockages in those vessels. In this animal study, the novel technique achieved better results at a lower dose than conventional non-magnetic stent therapy.

20 Apr 2010

SMRMC selects ProVation Order Sets, powered by UpToDate Decision Support order set solution

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Southwest Mississippi Regional Medical Center (SMRMC) has selected ProVation® Order Sets, powered by UpToDate® Decision Support, as its electronic order set solution.

20 Apr 2010

$Innovative new contact lens to correct hyperopia without refractive surgery$

Innovative new contact lens to correct hyperopia without refractive surgery

Jaume Pauné, a graduate of the Master's Degree in Optometry and Vision Sciences at the UPC-Barcelona Tech's College of Optics and Optometry, has designed an innovative new contact lens that will improve the vision quality of thousands of people without surgery. The Spanish Association of Opticians and Optometrists has granted its National Award to Mr. Pauné for his innovative work in this field.

20 Apr 2010

CryoSTAT cold therapy for hemorrhoids

Revolutionary new CryoSTAT is here to put the fire out when it comes to hemorrhoids by treating them on contact with cold therapy which has a proven track record of providing instant relief with no mess.

20 Apr 2010

New technique that involves voice analysis to diagnose Parkinson's disease developed

A new technique assisting in early diagnosis of Parkinson's disease has been developed by Prof. Shimon Sapir of the Department of Communication Sciences and Disorders at the University of Haifa. This technique involves analysis of voice and articulation. The research was carried out alongside U.S. scientists and with funding from the National Institutes of Health, and results have been published in the Journal of Speech, Language, and Hearing Research.

20 Apr 2010

Device / Technology News

Genentech to pay Seattle Genetics $9.5M for renewing licenses under existing ADC collaboration agreement

Total Pricing Systems of Moncton introduces PPS Assist!

MDx to better health care, cut costs and make personalized medicine a worldwide reality

Investment report on Sequenom from MicroStockProfit.com

Medical device industry leaders to meet with lawmakers, government officials at MDMA annual meeting

AngioDynamics commences treatment in NanoKnife IRE System pilot study for HCC

STERIS reaches agreement with FDA over liquid chemical sterilization system consent decree

ATS Medical announces first ATS 3f Aortic Bioprosthesis commercial implant in China

Optimal IMX implements MobileMD's HIE technologies and services

NextBio announces new Sequence-Centric module for mining high throughput array and sequencing data

Calmare pain therapy medical device reviewed at CTT's annual meeting of shareholders

Wellstar International to install TMI Imaging system in Torrance, California

Pre-clinical study results of BiTE antibody technology presented at AACR 2010

Gamma-prime fibrinogen test can help better predict people at risk for heart attack

EHSI incorporates outpatient treatment options into MedAnywhere HHC Module

Magnetically guided nanoparticles for delivering DNA, cells and drugs

SMRMC selects ProVation Order Sets, powered by UpToDate Decision Support order set solution

Innovative new contact lens to correct hyperopia without refractive surgery

CryoSTAT cold therapy for hemorrhoids

New technique that involves voice analysis to diagnose Parkinson's disease developed

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News